We have no idea when a vaccine combating the deadly COVID-19 virus will be available.

But when the time comes, whether it’s in six months, a year or more, there will likely be several vaccines from different companies available.

Investors who have piled in to pharma stocks in the past six months think the companies that are first to market with a coronavirus vaccine will profit.

But I don’t think that applies to all of them — at least not in the long term.

The deck is stacked against one company in particular — and any gains from a vaccine will be temporary at best.

In this episode of The Bull & The Bear, I reveal the one COVID-19 vaccine stock that you should stay away from at all costs.

I researched all of the companies involved in developing a vaccine — and I have to tell you about this one stock to avoid.

Be sure to also subscribe to our YouTube channel for more videos and information.

Have something you want us to talk about? Email us at thebullandthebear@moneyandmarkets.com and give us your thoughts.

Check out MoneyandMarkets.com and sign up for our free newsletters. They deliver you the most important and unbiased financial news, commentary and actionable advice — seven days a week.

Also, follow us on:

Facebook

Twitter

LinkedIn